The Gene Therapy Approved in 2024 That Cost More Than a House

In March 2024, the FDA approved a gene therapy called Lenmeldy that costs $4.25 million for a single treatment — more than the median price of a home in...

In March 2024, the FDA approved a gene therapy called Lenmeldy that costs $4.25 million for a single treatment — more than the median price of a home in...

The tropical disease medication most international travelers need before departure is an antimalarial drug — and the one you choose matters more than you...

A lumbar disc herniation rarely announces itself with a single dramatic episode of crippling back pain.

A new class of oral medications called BTK inhibitors is poised to change the trajectory of multiple sclerosis by intercepting the disease's destructive...

After decades without a single FDA-approved option, molluscum contagiosum finally has not one but two prescription treatments available in the United...

In July 2022, the FDA approved Opzelura (ruxolitinib cream, 1.5%) as the first-ever pharmacologic treatment specifically designed to restore pigmentation...

Most glaucoma patients who are prescribed eye drops will stop using them within a year. That is not speculation — research shows that roughly 50 percent...

Despite the hopeful framing of this headline, no new drug has actually been approved by the FDA for alcohol use disorder as of early 2026.

Your medication looks different because U.S. trademark laws actually prohibit generic drugs from copying the exact appearance of brand-name pills.

The medication error that kills thousands of Americans every year is not some rare pharmacological mystery.
HelpDementia.com
Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance
© 2026 HelpDementia.com. All rights reserved.
Educational information only. It is not medical advice and does not replace care from a qualified clinician.